Simple Summary In recent decades, neoadjuvant chemotherapy has proven to be a viable
therapeutic option, particularly in cases of high-risk early or locally advanced breast cancer …

Simple Summary Endocrine therapy is a common treatment for estrogen-responsive breast
cancer, which is used to block the tumor growth-promoting effect of this hormone. The …

Neo-adjuvant therapy (NAT) is increasingly used in the clinic for the treatment of breast
cancer (BC). Pathological response to NAT has been associated with improved patients' …

Breast cancer (BC) is a leading cause of cancer-related deaths among women worldwide.
Neoadjuvant therapy (NAT) is increasingly being used to reduce tumor burden prior to …

Over the past two decades, liquid biopsy has been increasingly used as a supplement, or
even, a replacement to the traditional biopsy in clinical oncological practice, due to its …

The three most common genitourinary malignancies (prostate/kidney/bladder cancers)
constitute a substantial proportion of all cancer cases, mainly in the elderly population. Early …

Breast cancer is a generalized global problem. Biomarkers are the active substances that
have been considered as the signature of the existence and evolution of cancer. Early …

Renal cell carcinoma (RCC) remains a formidable diagnostic challenge, especially in the
context of small renal masses. The quest for non-invasive screening tools and biomarkers …

Simple Summary In breast cancer management, neoadjuvant chemotherapy is well
established as therapeutic choice for selected high-risk early or locally advanced breast …

Background The incidence of obesity, a known risk factor for several metabolic and chronic
diseases, including numerous malignancies, has risen sharply in the world. Various clinical …